Relentless pursuit of therapeutics

that slow/stop the progression of Parkinson's disease


Vincere's pipeline of small molecules is founded on a platform of molecular mechanisms implicated in pathogenesis of Parkinson's disease through an exclusive license to patented simulation of human data & AI from:


Support for Vincere's discovery platform and pipeline provided by private investors and:


More info:


Multiple programs are underway to restore mitochondrial health in Parkinson's disease and related neurodegenerative disorders.